Quiet Insider Buying Shortened Week May 29th 2020
Jazz Pharmaceutical Director Seamus Mulligan bought 50,000 shares at $111.08. Before investors pile in behind that enforcement, it’s worth considering Mulligan bought 50,000 shares back in 11/15/18 at $144.56. JAZZ had a few analyst downgrades after releasing last quarter’s earnings report. JAZZ is a leader in sleep medicine and has a growing hematology/oncology portfolio. Dynavax Technologies DVAX is a startup biotech. The priced a 14M share offering at $5 below the last closing price osf $5.66. Director Jack bought 1,000,000 shares at $5. Do you think he knew that DVAX would announce a week letter that Sky would report a … Read more